p16 mutation represents one of the two hits required to inactivate the gene, along with copy neutral LOH, deletion/copy loss LOH, or promoter hypermethylation; therefore, we examined the associations between p16 mutation, LOH and deletion in patients with BE. Here, CDKN2A is linked to Barrett esophagus.